HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)

HYUNDAI BIOLAND Revenue

HYUNDAI BIOLAND had revenue of 40.27B KRW in the quarter ending June 30, 2026, with 16.35% growth. This brings the company's total for the last twelve months to 140.70B, up 11.51% year-over-year. In the year 2025, HYUNDAI BIOLAND had annual revenue of 130.51B with 9.19% growth. That makes HYUNDAI BIOLAND the 22,200th largest company in the world by revenue and 1,240th in South Korea.

• Revenue (ttm): 140.70B
• Revenue Growth: +11.51%
• P/S Ratio: 0.92
• Revenue / Employee: 416.27M
• Employees: 338
• Market Cap: 129.75B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Manufacture of Cosmetics and Pharmaceutical Raw Materials 130.50B 99.8%
• Chinese Cosmetics Raw Material Manufacturing 319.26M 0.2%

By Geography

Chart

• South Korea 102.47B 78.5%
• Other 11.73B 9.0%
• China 9.92B 7.6%
• United States of America 3.85B 3.0%
• Japan 2.53B 1.9%

Fiscal year ended Dec 31, 2025 See the full HYUNDAI BIOLAND breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	130.51B	10.99B	9.19%
Dec 31, 2024	119.52B	22.80B	23.57%
Dec 31, 2023	96.72B	-2.43B	-2.45%
Dec 31, 2022	99.15B	-3.65B	-3.55%
Dec 31, 2021	102.80B	13.90B	15.64%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error